Peptides Targeting Fms-Related Tyrosine Kinase-4 Activate the Function of Natural Killer Cells in Acute Myeloid Leukemia

Soojin PARK; Hee-Je KIM; Hee-Sun HWANG; A-Reum HAN.
International Journal of Stem Cells ; : 400-409, 2021.
Artículo en Inglés | WPRIM | ID: wpr-914655

Documentos relacionados

  1. Therapeutic potential of FLT4-targeting peptide in acute myeloid leukemia.
  2. Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion.
  3. Peptides Targeting Fms-Related Tyrosine Kinase-4 Activate the Function of Natural Killer Cells in Acute Myeloid Leukemia.
  4. Expression and Function of VEGFRs in Normal Epidermis and Psoriatic Lesional Keratinocytes.
  5. Formation of the glomerular microvasculature is regulated by VEGFR-3.
  6. FLT4 as a marker for predicting prognostic risk of refractory acute myeloid leukemia.
  7. A VEGFR-3 antagonist increases IFN-γ expression on low functioning NK cells in acute myeloid leukemia.
  8. Homodimeric peptide radiotracer [<sup>68</sup>Ga]Ga-NOTA-(TMVP1)<sub>2</sub> for VEGFR-3 imaging of cervical cancer patients.
  9. Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through ß-Arrestin 1.
  10. Fibroblast Growth Factor 19-Mediated Up-regulation of SYR-Related High-Mobility Group Box 18 Promotes Hepatocellular Carcinoma Metastasis by Transactivating Fibroblast Growth Factor Receptor 4 and Fms-Related Tyrosine Kinase 4.